This is the legacy version of We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center. Sep 11
Replying to @Lymenews
Leigner | "5 of 67 patients (7.5%) reported either no benefit or unclear benefit from application of disulfiram It is unclear whether a low dose regimen can yield 'enduring remission' after discontinuation of treatment."